Health Condition 1: L80- Vitiligo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Male or female patient with confirmed leucoderma due to genetic or non-genetic reason can be included in the study.
Exclusion criteria
Exclusion criteria: Female patients having pregnancy, breast feeding or post-delivery period. Patients having evidence of extensive disease or any other treatment is continue. Patients having patches or white spots due to chemical or burning hazard.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin color will be changed towards normal from hyperpigmentation. This will be evaluated using the method given by Geel et al. (2020). 1. confetti-like depigmentation 2. Koebner phenomenon 3. hypochromic areas/borders Timepoint: Time-point is 4 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Size of the white patches or number of white patches will be reduced. The size of the white patches may be measured by putting a transparent plastic sheet on the skin & draw the area of the patch using pointed marker pen. The scoring method to assess the effect of the treatment will be adopted. Timepoint: Time points will be, measurement at the end of the 1st 2nd 3rd & 4th week of the treatment. | — |
Countries
India
Contacts
Faculty of Pharmacy, Dharmsinh Desai University